Skip to content

US · MDAI · MEDICAL - SPECIALTIES

Spectral AI, Inc. (MDAI) intrinsic value and stock valuation

$1.04as of 2026-11-21 · Mkt cap 51.87M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Spectral AI, Inc. DCF and intrinsic value

InvestorsCraft values MDAI with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from MDAI’s statements →

Spectral AI, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Specialties Dallas, TX 75201 spectral-ai.com

How the business is doing

Fiscal 2021–2025, USD

Revenue
$19.7M
20212025
Net income
-$-7.57M
20212025
Free cash flow
-$-9.92M
20212025
Total equity
-$-5.73M
20202025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2021–2025, USD
20252024202320222021
Revenue$19.7M$29.6M$18.1M$25.4M$15.2M
Operating income-$-8.6M-$-6.58M-$-12.98M-$-2.65M-$-4.18M
Net income-$-7.57M-$-15.31M-$-20.85M-$-2.91M-$-3.99M
EPSd-$-285.44K-$-853.88K-$-1.48M-$-162.75K-$-223.15K
Operating cash flow-$-9.92M-$-9.2M-$-13.24M-$-1.16M-$-2.92M
Capital expenditure$0.00$0.00$0.00$0.00-$-10K
Free cash flow-$-9.92M-$-9.2M-$-13.24M-$-1.16M-$-2.92M
Total assets$21.4M$12.1M$10.7M$18.7M$18.5M
Total debt$10.1M$4.69M$1.29M$1.2M$580K
Net debt-$-5.3M-$-470K-$-3.5M-$-12.97M-$-15.54M
Total equity-$-5.73M-$-7.25M-$-1.71M$12M$13.8M
Cash and short-term investments$15.4M$5.16M$4.79M$14.2M$16.1M
Income statement
20252024202320222021
Revenue$19.7M$29.6M$18.1M$25.4M$15.2M
Cost of revenue$10.7M$16.3M$10.2M$14.5M$8.19M
Gross profit$8.93M$13.3M$7.88M$10.8M$7.05M
Research and development expenses$19.7M$29.6M$0.00$0.00$0.00
Selling, general and administrative expenses$17.5M$19.9M$20.9M$13.5M$11.2M
Other expenses-$-19.65M-$-29.58M$0.00$0.00$0.00
Operating expenses$17.5M$19.9M$20.9M$13.5M$11.2M
Cost and expenses$28.3M$36.2M$31M$28M$19.4M
Interest income-$-890K$10K$170K$20K$0.00
Interest expense$1.51M$2.96M$0.00$0.00$0.00
Depreciation and amortization$640K$590K$720K$570K$0.00
Ebitda-$-5.42M-$-11.49M-$-20.12M-$-2.24M-$-4.08M
Operating income-$-8.6M-$-6.58M-$-12.98M-$-2.65M-$-4.18M
Total other income/expenses, net$1.04M-$-8.46M-$-7.86M-$-160K$90K
Income before tax-$-7.56M-$-15.04M-$-20.84M-$-2.81M-$-4.09M
Income tax expense$10K$270K$10K$110K-$-100K
Net income-$-7.57M-$-15.31M-$-20.85M-$-2.91M-$-3.99M
Weighted average shares outstanding$26.5M$17.9M$14.1M$17.9M$17.9M
Weighted average diluted shares outstanding$26.5M$17.9M$14.1M$17.9M$17.9M
Balance sheet
20252024202320222021
Cash and short-term investments$15.4M$5.16M$4.79M$14.2M$16.1M
Net receivables$1.27M$2.5M$2.35M$2.91M$1.51M
Inventory$840K$420K$230K$0.00$0.00
Total current assets$19.5M$10.1M$9.9M$17.7M$18.5M
Property, plant and equipment, net$1.67M$1.97M$790K$1.03M$30K
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$4.63M$253M
Total non-current assets$1.95M$1.97M$790K$1.03M$70K
Total assets$21.4M$12.1M$10.7M$18.7M$18.5M
Accounts payable$3.01M$4.04M$2.68M$2.76M$1.41M
Short-term debt$3.59M$2.99M$1.29M$850K$580K
Deferred revenue$150K$960K$2.31M$0.00$20K
Total current liabilities$20.6M$17.6M$12.4M$6.37M$4.79M
Long-term debt$6.51M$1.7M$0.00$350K$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$6.51M$1.7M$0.00$350K$19M
Capital lease obligations$730K$1.9M$850K$1.03M$0.00
Total liabilities$27.1M$19.4M$12.4M$6.72M$4.79M
Common stock$0.00$0.00$0.00$0.00$140K
Retained earnings-$-55.8M-$-48.1M-$-32.79M-$-11.93M-$-9.02M
Accumulated other comprehensive income (loss)$40K$0.00$10K$0.00$0.00
Total equity-$-5.73M-$-7.25M-$-1.71M$12M$13.8M
Total investments$0.00$0.00$0.00$4.63M$253M
Total debt$10.1M$4.69M$1.29M$1.2M$580K
Net debt-$-5.3M-$-470K-$-3.5M-$-12.97M-$-15.54M
Cash flow statement
20252024202320222021
Net income-$-7.57M-$-15.31M-$-20.85M-$-2.91M-$-3.99M
Depreciation and amortization$640K$590K$720K$570K$0.00
Stock-based compensation$1.11M$1.03M$1.24M$1.16M$1.36M
Change in working capital-$-2.03M-$-1.87M$1.63M$80K$0.00
Accounts receivable$1.24M-$-160K$570K-$-1.41M$1.19M
Inventory-$-410K-$-200K-$-230K$0.00$0.00
Accounts payable-$-1.02M$1.43M-$-940K$1.34M-$-2.4M
Net cash provided by operating activities-$-9.92M-$-9.2M-$-13.24M-$-1.16M-$-2.92M
Investments in property, plant and equipment$0.00$0.00$0.00$0.00-$-10K
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities$0.00$0.00$0.00$0.00-$-10K
Common stock issued$13.4M$4.06M$3.35M$0.00$14.6M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$20.1M$9.57M$3.84M-$-790K$13.9M
Net change in cash$10.2M$370K-$-9.38M-$-1.95M$11M
Cash at end of period$15.4M$5.16M$4.79M$14.2M$16.1M
Operating cash flow-$-9.92M-$-9.2M-$-13.24M-$-1.16M-$-2.92M
Capital expenditure$0.00$0.00$0.00$0.00-$-10K
Free cash flow-$-9.92M-$-9.2M-$-13.24M-$-1.16M-$-2.92M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Spectral AI, Inc.

        Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.

        CEO
        Vincent S. Capone
        Employees
        65
        Beta
        1.17

        Explore

        Frequently asked questions

        What is the intrinsic value of Spectral AI, Inc. (MDAI)?

        InvestorsCraft does not currently publish an intrinsic value for MDAI. How the IC value is calculated.

        Is MDAI undervalued?

        InvestorsCraft does not publish an undervaluation signal for MDAI at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.